Posts by: Nieke Vanavermaete
- Covid-19 coronavirus: Measures affecting the Belgium life sciences sector
- Covid-19 coronavirus: New guidance on managing clinical trials in Belgium
- EU data protection guidance on Covid-19 apps
- Belgium - New Bill on allowing access to confidential agreements between government and pharmaceutical companies
- EMA takes specific steps to reduce possible impact of Covid-19 on pharmaceutical supply chain in EU
Subscribe to our newsletter×
You can customise your daily newsletter by ticking the boxes below. You will only receive updates concerning your areas of interest.